Teladoc Health (TDOC)
Provides virtual medical care, chronic-condition programs, and online therapy.
$6.19
vs last close−0.17 (−2.60%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 660 | 661 | 646 | 642 | 641 | 640 | 629 | 632 | 626 | 642 | 614 | 607 |
| Cost of revenue | 186 | 193 | 195 | 188 | 180 | 189 | 197 | 191 | 187 | 197 | 290 | −15 |
| Gross profit | 474 | 467 | 452 | 454 | 461 | 452 | 433 | 441 | 439 | 445 | 324 | 622 |
| 539 | 502 | 539 | 1,296 | 505 | 500 | 553 | 496 | 491 | 481 | 373 | 659 | |
| Research & development | 107 | 31 | 81 | 108 | 108 | 21 | 70 | 113 | 68 | 72 | 68 | 63 |
| 354 | 310 | 349 | 330 | 339 | 327 | 330 | 326 | 222 | 208 | 305 | 297 | |
| Selling & marketing | 238 | 201 | 238 | 221 | 225 | 227 | 217 | 217 | 119 | 100 | 203 | 193 |
| General & administrative | 116 | 109 | 112 | 110 | 114 | 100 | 113 | 108 | 103 | 108 | 102 | 104 |
| Other expenses | 78 | 162 | 108 | 858 | 58 | 152 | 154 | 57 | 202 | 201 | 0 | 299 |
| Operating income | −65 | −35 | −87 | −841 | −44 | −48 | −121 | −54 | −52 | −36 | −49 | −37 |
| 5 | 10 | 8 | 7 | 12 | 0 | 9 | 14 | 2 | 2 | −12 | −1 | |
| Interest income | 13 | 14 | 14 | 14 | 15 | 14 | 13 | 10 | 53 | 39 | 6 | 6 |
| Interest expense | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 4 | 5 | 5 | 5 | 5 |
| Other non-operating income | −6 | −5 | −10 | −792 | −4 | −6 | −66 | −8 | −6 | −7 | 7 | −7 |
| Income before tax | −60 | −25 | −79 | −834 | −32 | −48 | −111 | −40 | −50 | −34 | −61 | −38 |
| Income tax expense | −2 | 4 | 3 | 4 | 1 | 0 | −18 | −8 | −1 | −8 | 3 | 1 |
| Net income from continuing operations | −57 | −29 | −82 | −838 | −33 | −48 | −93 | −33 | −50 | −25 | −64 | −39 |
| Net income | −57 | −29 | −82 | −838 | −33 | −48 | −93 | −33 | −50 | −25 | −64 | −39 |
| EPS, basic | −$0.35 | −$0.17 | −$0.49 | −$4.92 | −$0.20 | −$0.28 | −$0.53 | −$0.19 | −$0.28 | −$0.14 | −$0.36 | −$0.21 |
| EPS, diluted | −$0.35 | −$0.17 | −$0.49 | −$4.92 | −$0.19 | −$0.28 | −$0.53 | −$0.19 | −$0.28 | −$0.14 | −$0.36 | −$0.21 |
| Weighted average shares, basic | 165 | 166 | 168 | 170 | 170 | 173 | 174 | 176 | 176 | 176 | 179 | 180 |
| Weighted average shares, diluted | 165 | 166 | 168 | 170 | 171 | 173 | 174 | 176 | 176 | 176 | 179 | 180 |
| EBITDA | 13 | 44 | −10 | 17 | 13 | 12 | −9 | 3 | −35 | 51 | 39 | −125 |
| Depreciation & amortization | 72 | 74 | 67 | 66 | 54 | 54 | 46 | 49 | 11 | 80 | 94 | −94 |
| EBIT | −58 | −30 | −77 | −49 | −40 | −42 | −55 | −46 | −46 | −29 | −55 | −30 |
